Raia Drogasil SA
BOVESPA:RADL3
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
44B BRL |
Loading...
|
|
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
76.6B ZAR |
Loading...
|
|
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
31.6B ZAR |
Loading...
|
|
| JP |
|
Sapporo Clinical Laboratory Inc
TSE:9776
|
3.1T JPY |
Loading...
|
|
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD |
Loading...
|
|
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
1.2T JPY |
Loading...
|
|
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
1T JPY |
Loading...
|
|
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR |
Loading...
|
|
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
29.4B CNY |
Loading...
|
|
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY |
Loading...
|
|
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
646.6B JPY |
Loading...
|
Market Distribution
| Min | -6 965.9% |
| 30th Percentile | 2.1% |
| Median | 8.9% |
| 70th Percentile | 15.5% |
| Max | 1 493% |
Other Profitability Ratios
Raia Drogasil SA
Glance View
Raia Drogasil SA, Brazil's pharmaceutical titan, stands as a testament to the transformative power of strategic mergers and innovative retail management. Born out of the merger of Drogasil and Droga Raia, two of Brazil's enduring pharmacy chains, the company today operates an extensive network of retail stores across the nation. This strategic merger in 2011 was not merely a consolidation of operations but a fusion of distinct corporate cultures and expertise, aimed at enhancing operational efficiencies and expanding market share. By leveraging economies of scale, Raia Drogasil has entrenched itself as a formidable force in Brazil's healthcare retail sector, boasting a strong presence in both high-density urban centers and emerging markets in Brazil. The company's business model is built on a robust mix of health and wellness products, encompassing everything from prescription medications to over-the-counter remedies and personal care items. Raia Drogasil has adeptly positioned itself to capitalize on Brazil's growing healthcare demands, thanks to its comprehensive product offerings and strategic store locations. Each store functions as both a destination for health-conscious consumers and a vital link in the greater logistical chain that ensures timely product availability. By intertwining brick-and-mortar retail with digital innovation, Raia Drogasil not only drives revenue through traditional sales channels but also through its dynamic e-commerce platform. This synergy allows the company to tap into the evolving preferences of tech-savvy consumers, thereby making Raia Drogasil a leader in seamlessly integrating shopping experiences that cater to modern customer expectations.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Raia Drogasil SA is 3%, which is below its 3-year median of 3.1%.
Over the last 3 years, Raia Drogasil SA’s Net Margin has decreased from 3.1% to 3%. During this period, it reached a low of 2.9% on Jun 30, 2024 and a high of 3.4% on Mar 31, 2023.